Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?
AIM: To determine the association between the neutrophil to lymphocyte (N/L) ratio and the degree of liver fibrosis in patients with chronic hepatitis B (CHB) infection.
METHODS: Between December 2011 and February 2013, 129 consecutive CHB patients who were admitted to the study hospitals for histological evaluation of chronic hepatitis B-related liver fibrosis were included in this retrospective study. The patients were divided into two groups based on the fibrosis score: individuals with a fibrosis score of F0 or F1 were included in the "no/minimal liver fibrosis" group, whereas patients with a fibrosis score of F2, F3, or F4 were included in the "advanced liver fibrosis" group. The Statistical Package for Social Sciences 18.0 for Windows was used to analyze the data. A P value of < 0.05 was accepted as statistically significant.
RESULTS: Three experienced and blinded pathologists evaluated the fibrotic status and inflammatory activity of 129 liver biopsy samples from the CHB patients. Following histopathological examination, the "no/minimal fibrosis" group included 79 individuals, while the "advanced fibrosis" group included 50 individuals. Mean (N/L) ratio levels were notably lower in patients with advanced fibrosis when compared with patients with no/minimal fibrosis. The mean value of the aspartate aminotransferase-platelet ratio index was markedly higher in cases with advanced fibrosis compared to those with no/minimal fibrosis.
CONCLUSION: Reduced levels of the peripheral blood N/L ratio were found to give high sensitivity, specificity and predictive values in CHB patients with significant fibrosis. The prominent finding of our research suggests that the N/L ratio can be used as a novel noninvasive marker of fibrosis in patients with CHB.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
World journal of gastroenterology - 21(2015), 18 vom: 14. Mai, Seite 5575-81 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kekilli, Murat [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Aspartate Aminotransferases |
|---|
| Anmerkungen: |
Date Completed 11.04.2016 Date Revised 17.03.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3748/wjg.v21.i18.5575 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM249145863 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM249145863 | ||
| 003 | DE-627 | ||
| 005 | 20231224152937.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2015 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3748/wjg.v21.i18.5575 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0830.xml |
| 035 | |a (DE-627)NLM249145863 | ||
| 035 | |a (NLM)25987782 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kekilli, Murat |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B? |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.04.2016 | ||
| 500 | |a Date Revised 17.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a AIM: To determine the association between the neutrophil to lymphocyte (N/L) ratio and the degree of liver fibrosis in patients with chronic hepatitis B (CHB) infection | ||
| 520 | |a METHODS: Between December 2011 and February 2013, 129 consecutive CHB patients who were admitted to the study hospitals for histological evaluation of chronic hepatitis B-related liver fibrosis were included in this retrospective study. The patients were divided into two groups based on the fibrosis score: individuals with a fibrosis score of F0 or F1 were included in the "no/minimal liver fibrosis" group, whereas patients with a fibrosis score of F2, F3, or F4 were included in the "advanced liver fibrosis" group. The Statistical Package for Social Sciences 18.0 for Windows was used to analyze the data. A P value of < 0.05 was accepted as statistically significant | ||
| 520 | |a RESULTS: Three experienced and blinded pathologists evaluated the fibrotic status and inflammatory activity of 129 liver biopsy samples from the CHB patients. Following histopathological examination, the "no/minimal fibrosis" group included 79 individuals, while the "advanced fibrosis" group included 50 individuals. Mean (N/L) ratio levels were notably lower in patients with advanced fibrosis when compared with patients with no/minimal fibrosis. The mean value of the aspartate aminotransferase-platelet ratio index was markedly higher in cases with advanced fibrosis compared to those with no/minimal fibrosis | ||
| 520 | |a CONCLUSION: Reduced levels of the peripheral blood N/L ratio were found to give high sensitivity, specificity and predictive values in CHB patients with significant fibrosis. The prominent finding of our research suggests that the N/L ratio can be used as a novel noninvasive marker of fibrosis in patients with CHB | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Chronic hepatitis B | |
| 650 | 4 | |a Fibrotic stage | |
| 650 | 4 | |a Inflammatory activity | |
| 650 | 4 | |a Liver fibrosis | |
| 650 | 4 | |a Neutrophil to lymphocyte ratio | |
| 650 | 4 | |a Non-invasive marker | |
| 650 | 7 | |a Aspartate Aminotransferases |2 NLM | |
| 650 | 7 | |a EC 2.6.1.1 |2 NLM | |
| 700 | 1 | |a Tanoglu, Alpaslan |e verfasserin |4 aut | |
| 700 | 1 | |a Sakin, Yusuf Serdar |e verfasserin |4 aut | |
| 700 | 1 | |a Kurt, Mevlut |e verfasserin |4 aut | |
| 700 | 1 | |a Ocal, Serkan |e verfasserin |4 aut | |
| 700 | 1 | |a Bagci, Sait |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t World journal of gastroenterology |d 1997 |g 21(2015), 18 vom: 14. Mai, Seite 5575-81 |w (DE-627)NLM117065250 |x 2219-2840 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2015 |g number:18 |g day:14 |g month:05 |g pages:5575-81 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3748/wjg.v21.i18.5575 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2015 |e 18 |b 14 |c 05 |h 5575-81 | ||